Promise Advanced Proteomics was created in 2010 and is now a full subsidiary of the Aguettant group. Promise Proteomics is based in Grenoble, France. Promise Proteomics ethos is to develop innovative mass spectrometry-based technologies to address protein absolute quantification in biological samples. Promise protects its innovative developments by national and international patents and brands. These rights secure the exclusive marketing of our unique products and thus contribute to the economic success of our company.

Our stable isotope labelled, and unlabelled full-length recombinant protein products are used by customers involved in these main application areas:

Biomarkers evaluation and validation
Pharmacokinetics studies of biotherapeutics
Development of Certified Reference Materials
Quantitation of therapeutic monoclonal antibodies in clinical research studies